Exxon ‘Odd One Out’ on Share Buybacks Even as Profits Soar
(Bloomberg) -- Exxon Mobil Corp. just posted its biggest third-quarter profit in years but unlike peers it won't be spending any of that cash on buybacks.
Royal Dutch Shell Plc this week expanded share repurchases by 25 percent to $2.5 billion. Meanwhile, Chevron Corp. is open to expanding the buyback program initiated earlier this year if crude prices remain high, Chief Financial Officer Pat Yarrington said during a conference call Friday.
Exxon, however, remains steadfastly against the idea, prompting Raymond James Financial Inc. analyst Pavel Molchanov to cast the company as the “odd one out” among major oil producers.
“We're not going to prioritize buybacks,” Neil Hansen, Exxon's investor relations chief, said during a conference call. The oil giant instead wants to focus on dividends and growth projects, he said.
That hasn't gone down well with investors. The stock dipped into negative territory around midday Friday, compared with Chevron's 2.8 percent advance.
“There is room to reinstate share buyback (beyond simply offsetting dilution), even assuming a price deck less bullish than ours,” Molchanov said in a note. “However, management is still not pulling the trigger.”
To contact the reporter on this story: Kevin Crowley in Houston at kcrowley1@bloomberg.net
To contact the editors responsible for this story: Simon Casey at scasey4@bloomberg.net, Joe Carroll, Margot Habiby
©2018 Bloomberg L.P.
-
Indians Stay With Family, Not In Hotels | The Reason Why
India still lacks enough clean, reliable and affordable hotels for budget-conscious travellers.
-
The Economic Imperative: Analysing The Material Driving Force Behind India-Canada Strategic Reset
This economic complementarity is further reinforced by deep institutional investment ties and talent mobility, which form the bedrock of the bilateral framework.
-
Medicine Pricing: Where Must Profit Stop?
India must confront excessive margins, hidden incentives and regulatory gaps that threaten the integrity of medicine.
-
Why Amazon And Flipkart Are Struggling To Beat Meesho In India's Smaller Cities
With 274 million users and lowest-cost logistics, Meesho is defending its value commerce crown against giants like Amazon and Flipkart.
-
High US Salaries, No Green Card Certainty: The Financial Calculation Facing Indian H-1B Families
The suspension of PERM processing at eight technology employers does not cancel existing H-1B visas. What it does is force a question many Indian families have been avoiding: is the US salary worth tying your career and family plans to one employer?
-
Swiggy vs Eternal: Food Delivery's Two Rivals Are No Longer In The Same Race
Eternal is building a private AI assistant, dark.ai. Swiggy is still working out how to make Instamart pay, with an operating loss of Rs 895 crore in the July-September quarter while Blinkit stayed profitable.
-
Where You Live Shapes How You Get To Work | The Reason Why
Two-wheelers are the most popular way to get to work in India, accounting for nearly 43% of workplace commutes.
-
Unhedged Position: Can India See An Indonesia-Style Time Correction?
The Nifty is trading below levels it first clocked in 2024. Is there, then, as I have suggested in the headline, potential that the current time correction drags on painfully for the next three-five, even ten years?
-
Navigating Friction And Energy Realities: An Analysis Of Marco Rubio's October Visit To India
Occurring at a critical juncture marked by stalled trade negotiations and escalating geopolitical pressures over global energy supplies, the visit offers a profound window into modern US-India relations.
-
India Exports Capital. Why Not Export Trusteeship?
The big question, then, is whether India can build an institution that global borrowers, investors, banks, and lawyers can trust, even without an Indian connection.